German Other Utilities Stock News

XTRA:MBG
XTRA:MBGAuto

Weaker Q1 Earnings and US Tariff Risks Might Change The Case For Investing In Mercedes-Benz Group (XTRA:MBG)

In the first quarter of 2026, Mercedes-Benz Group AG reported sales of €25,497 million and net income of €1,418 million, both lower than a year earlier. At the same time, renewed US tariff threats on European cars have added policy uncertainty to Mercedes-Benz’s already pressured automotive earnings profile. Next, we’ll explore how weaker quarterly profitability amid renewed US tariff risks could influence Mercedes-Benz Group’s existing investment narrative. The latest GPUs need a type of...
XTRA:MRK
XTRA:MRKPharmaceuticals

A Look At Merck KGaA (XTRA:MRK) Valuation After Advancing Enpatoran To Global Phase 3 Lupus Trials

Merck KGaA (XTRA:MRK) has drawn fresh attention after dosing the first patient in its global Phase 3 ELOWEN-1 and ELOWEN-2 trials of enpatoran in lupus with active skin manifestations, marking a late stage pipeline milestone. See our latest analysis for Merck KGaA. The ELOWEN Phase 3 update and the recent Hybrid Drugs collaboration with Remepy come as Merck KGaA’s 7 day share price return of 5.08% and 1 day gain of 2.85% contrast with a 1 year total shareholder return decline of 4.23% and a 3...
XTRA:BC8
XTRA:BC8IT

Bechtle (XTRA:BC8) Reaffirms Dividend After Weaker Earnings Is Its Capital Allocation Story Shifting?

Bechtle AG has announced an annual dividend of €0.70 per share, with an ex-date of 18 June 2026, record date of 19 June 2026, and payment on 22 June 2026. This dividend affirmation comes shortly after earnings revealed weaker profitability and reduced operating cash flow, highlighting a tension between shareholder payouts and near-term financial pressures. We’ll now examine how the dividend affirmation, set against weaker profitability and cash generation, could reshape Bechtle’s existing...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Bayer Reshapes Pharma And Crop Science With Perfuse Deal And bp Alliance

Bayer has agreed to acquire Perfuse Therapeutics, its largest drug deal in years, to expand its ophthalmology portfolio. The company announced a new alliance with bp to develop and commercialize camelina as a feedstock for sustainable fuels. Phase III REVEAL study results for Bayer's cardiac imaging agent in diagnostics were reported as positive. Bayer (XTRA:BAYN), trading around €38.51, is trying to reshape both its pharmaceuticals and crop science businesses after a mixed share price...
XTRA:CON
XTRA:CONAuto Components

Continental (XTRA:CON) Q1 Profit Of €193m Tests Turnaround Narratives Against Trailing Loss

Continental (XTRA:CON) opened 2026 with Q1 revenue of €4.4b and basic EPS of €0.97, setting the tone for how investors weigh its loss making trailing 12 month profile against the latest quarterly snapshot. Over recent quarters, revenue has moved between €4.7b and €5.2b while basic EPS has ranged from a loss of €3.78 per share to a high of €12.95. This highlights how swings in profitability have shaped the story more than top line shifts. For investors, the key question now is whether recent...
XTRA:R3NK
XTRA:R3NKMachinery

RENK Group (XTRA:R3NK) Triple Digit EPS Growth Reinforces Bullish Profitability Narratives

RENK Group (XTRA:R3NK) has opened Q1 2026 with revenue of €283.6 million and basic EPS of €0.15, setting the tone for how the year is shaping up after a busy 2025. Revenue has moved from €272.6 million in Q1 2025 to €283.6 million in Q1 2026, while basic EPS has shifted from €0.01 to €0.15 over the same period, giving you a clearer sense of how the top and bottom lines are tracking into the new fiscal year. With trailing net profit margin sitting at 8.4% and five year earnings growth running...
XTRA:ELG
XTRA:ELGSemiconductor

A Look At Elmos Semiconductor (XTRA:ELG) Valuation After Raised 2026 Sales And Margin Guidance

Q1 2026 earnings and guidance change Elmos Semiconductor (XTRA:ELG) reported first quarter 2026 sales of €152.49 million and net income of €26.18 million, and then raised full year sales growth and EBIT margin guidance on continued high demand. See our latest analysis for Elmos Semiconductor. At a share price of €186.0, Elmos Semiconductor has seen strong momentum, with an 87.12% year to date share price return and a very large 1 year total shareholder return, although the 1 day share price...
DB:KZTA
DB:KZTATelecom

Kazakhtelecom (DB:KZTA) Net Margin Improvement Challenges Long‑Term Bearish Narratives

Kazakhtelecom JSC (DB:KZTA) has wrapped up FY 2025 with Q4 revenue of about ₸164.9 billion and a net loss from continuing operations of roughly ₸7.1 billion, setting a mixed backdrop for investors assessing the latest numbers. Over the past six reported quarters, revenue has shifted from about ₸123.2 billion in Q3 2024 to ₸164.9 billion in Q4 2025, while quarterly EPS has swung between a loss of about ₸294.5 and a high of roughly ₸2,363.3, with trailing 12 month EPS most recently sitting at...
XTRA:RWE
XTRA:RWERenewable Energy

Is It Too Late To Consider RWE (XTRA:RWE) After Its 85% One Year Rally?

Wondering whether RWE's share price still makes sense after a strong run, or if expectations have gone too far? This article focuses squarely on what the current price implies about value. RWE's stock closed at €59.42, with returns of 26.7% year to date and 85.0% over the last year, even though the last 7 days show a 2.0% decline and the last 30 days sit at 0.7%. Recent coverage has centered on RWE as a large European utility with significant exposure to renewable energy projects and ongoing...
XTRA:HAG
XTRA:HAGAerospace & Defense

Hensoldt (XTRA:HAG) Q1 Loss Tests Bullish Margin Expansion Narrative

How Hensoldt's Q1 2026 Numbers Set the Stage for the Story Ahead Hensoldt (XTRA:HAG) has opened 2026 with Q1 revenue of €496 million and a basic EPS loss of €0.16, alongside trailing twelve month EPS of €0.86 on €2.6 billion of revenue, which gives you a snapshot of a business that is profitable over the last year but loss making in the latest quarter. The company has seen quarterly revenue move from €395 million and EPS of €0.26 loss in Q1 2025 to €496 million and a €0.16 loss in Q1 2026,...
XTRA:TMV
XTRA:TMVSoftware

TeamViewer (XTRA:TMV) Margin Decline Tests Bullish Expansion Narrative After Q1 2026 Results

TeamViewer (XTRA:TMV) has opened Q1 2026 with revenue of €183.2 million and basic EPS of €0.22, setting the tone for how the market will judge its latest earnings season update. The company has seen quarterly revenue move from €178.8 million in Q1 2025 to €183.2 million in Q1 2026, while basic EPS shifted from €0.19 to €0.22 over the same period. Trailing twelve month EPS sits at €0.78 on revenue of €751.2 million, giving investors a view of the earnings power behind the current share price...
XTRA:RDC
XTRA:RDCConsumer Retailing

Redcare Pharmacy Q1 Loss Narrows Yet Ongoing Unprofitability Tests Bullish Margin Narratives

Redcare Pharmacy (XTRA:RDC) Q1 2026 earnings snapshot Redcare Pharmacy (XTRA:RDC) has posted Q1 2026 revenue of €849.5 million and a net loss of €10.5 million, setting the tone for how investors will read the stock at a share price of €45.98. The company has seen quarterly revenue move from €675.2 million in Q4 2024 to €849.5 million in Q1 2026, while trailing 12 month revenue sits at about €3.1 billion against a trailing net loss of €37.4 million. The latest print keeps the focus on how...
XTRA:GIL
XTRA:GILMachinery

DMG MORI (XTRA:GIL) Margin Compression In Q1 2026 Challenges Bullish Earnings Narrative

DMG MORI (XTRA:GIL) has opened Q1 2026 with revenue of €472.1 million and basic EPS of €0.15, setting the tone against a trailing twelve month backdrop where revenue sits at about €2.1 billion and EPS is €0.99. Over recent quarters, revenue has ranged between €456.7 million and €689.5 million, while basic EPS has moved from €0.21 in Q1 2025 to €0.76 in Q4 2024 and €0.44 in Q4 2025, giving you a clear line of sight on how the top and bottom line have been tracking into this latest print. With...
XTRA:ADS
XTRA:ADSLuxury

Assessing adidas (XTRA:ADS) Valuation After Strong Q1 2026 Earnings Performance

Q1 2026 earnings snapshot for adidas (XTRA:ADS) adidas (XTRA:ADS) opened 2026 with a first quarter earnings report that put fresh numbers in front of investors, including updated figures for sales, net income and earnings per share. See our latest analysis for adidas. The earnings release and recent athlete partnership news come after a mixed share price stretch, with a 1 month share price return of 9.93% but a year to date share price return decline of 11.41%. The 1 year total shareholder...
XTRA:MTX
XTRA:MTXAerospace & Defense

Are MTU Aero Engines' (XTRA:MTX) Rising Sales But Softer Earnings Reframing Its Margin Story?

MTU Aero Engines AG has released its first-quarter 2026 results, reporting sales of €2,231 million versus €2,111 million a year earlier, while net income eased to €200 million from €224 million and basic earnings per share from continuing operations moved to €3.59 from €4.03. The combination of higher revenue but lower profitability highlights pressure on margins, a key issue for a business so closely tied to engine program economics and aftermarket returns. We’ll now consider how this mix...
XTRA:BAS
XTRA:BASChemicals

Is BASF (XTRA:BAS) Offering Value After Its 29.4% One Year Share Price Return

Wondering if BASF at a last close of €52.42 is offering you value or just a fair price today? This article breaks down what the current share price might be implying. The stock has seen mixed short term moves, with a 3.0% decline over the last 7 days, a 2.9% return over 30 days, and a 17.1% return year to date, while the 1 year return sits at 29.4% and the 3 year and 5 year returns are 30.9% and 3.0% respectively. Recent news coverage around BASF has focused on its position within the...
XTRA:IFX
XTRA:IFXSemiconductor

Infineon Technologies (XTRA:IFX) Valuation After Strong Half Year 2026 Sales And Net Income Results

Infineon Technologies (XTRA:IFX) has attracted fresh attention after reporting half year results to March 31, 2026, with sales of €3,812 million and net income of €301 million, both above the prior period. See our latest analysis for Infineon Technologies. The earnings release and recent appearance at SEMICON SEA 2026 have coincided with strong momentum in the stock, with a 1 month share price return of 55.29% and a 1 year total shareholder return of 107.40%, suggesting investors have...